Curium patents expiration
1. Octreoscan patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5753627 | CURIUM | Use of certain complexed somatostatin peptides for the invivo imaging of somatostatin receptor-positive tumors and metastasis |
May, 2015
(8 years ago) | |
| US5776894 | CURIUM | Chelated somatostatin peptides and complexes thereof, pharmaceutical compositions containing them and their use in treating tumors |
Jul, 2015
(8 years ago) | |
| US6123916 | CURIUM | Therapeutic use of somatostatin peptides |
Sep, 2017
(6 years ago) | |
Drugs and Companies using INDIUM IN-111 PENTETREOTIDE KIT ingredient
Market Authorisation Date: 02 June, 1994
Treatment: Method for the detection of neuroendocrine tumors
Dosage: INJECTABLE;INJECTION
More Information on Dosage
OCTREOSCAN family patents
2. Technescan Mag3 patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5573748 | CURIUM | Radiolabeled technetium chelates for use in renal function determinations |
Nov, 2013
(10 years ago) | |
Drugs and Companies using TECHNETIUM TC-99M MERTIATIDE KIT ingredient
Market Authorisation Date: 15 June, 1990
Treatment: NA
Dosage: INJECTABLE;INJECTION
More Information on Dosage
TECHNESCAN MAG3 family patents